Birth Control Comparison: Pill vs IUD vs Implant — What the Evidence Shows

Why typical-use failure rates matter more than perfect-use rates

Every contraceptive comes with two failure rates: perfect use and typical use. Perfect use assumes the method is used correctly and consistently every single time. Typical use reflects how it performs in real life.

For the pill, this gap is significant. Perfect-use failure is approximately 0.3% per year. Typical-use failure — accounting for missed pills, late pills, and inconsistent timing — is around 9%. That's 9 pregnancies per 100 women over a year of use. For IUDs and implants, the gap is negligible because there is no user input required after insertion.

This is the most important number in contraceptive comparison, and it's frequently underemphasized in clinical consultations.

The combined oral contraceptive pill

The pill contains synthetic estrogen (usually ethinylestradiol) and a progestogen. It works primarily by suppressing ovulation. It also thickens cervical mucus and thins the uterine lining as secondary mechanisms.

The pill has the most flexibility: you can stop it at any time and fertility typically returns quickly. For women who want the pill's non-contraceptive benefits — lighter periods, acne control, endometriosis symptom management — it remains the most versatile option. Fertility returns within 1–3 months in most women after stopping.

The systemic estrogen is the source of most of the pill's meaningful risks: a modest increase in venous thromboembolism (VTE) risk, blood pressure effects, and the reason combined pills are contraindicated in women who have migraines with aura, are over 35 and smoke, or have certain cardiovascular risk factors.

Hormonal IUDs (LNG-IUDs)

Hormonal IUDs release levonorgestrel (a progestogen) directly into the uterine cavity. The systemic absorption is very low — substantially lower than the pill — which means most of the effect is local: thickening cervical mucus, thinning the uterine lining, and in higher-dose devices, suppressing ovulation intermittently.

A 2024 Lancet eClinicalMedicine meta-analysis comparing LNG-IUDs to copper IUDs found LNG-IUDs had a lower pregnancy risk and fewer adverse reactions overall. They also reduce menstrual bleeding significantly — many women experience lighter periods or amenorrhea, which many find desirable.

Available in the US: Mirena (52mg, up to 8 years), Kyleena (19.5mg, up to 5 years), Liletta (52mg, up to 8 years), Skyla (13.5mg, up to 3 years). The dose matters for side effect profile and which symptoms they help manage.

The copper IUD (Paragard)

No hormones at all. The copper itself creates an inhospitable uterine environment for sperm, with copper ions impairing sperm motility. Paragard is approved for up to 10 years and is 99%+ effective throughout that period.

The tradeoff is menstrual effects: heavier bleeding and more cramping are common, particularly in the first 3–6 months after insertion. For women with already-heavy periods or dysmenorrhea, the copper IUD can make things substantially worse. For women who had light periods, the increase is often more tolerable.

The copper IUD is also the most effective form of emergency contraception when inserted within 5 days of unprotected sex — 99%+ efficacy, significantly outperforming all oral emergency contraceptive options.

The implant (Nexplanon)

A small, flexible rod inserted under the skin of the upper arm. It releases etonogestrel (a progestogen) continuously and is now FDA-approved for up to 5 years (extended from 3 years in January 2025). Failure rate under 1 in 1,000 per year — one of the most effective methods available.

The main variable: bleeding patterns are unpredictable. Some women have minimal or no bleeding. Others experience frequent irregular spotting. About 1 in 5 women have the implant removed early due to bleeding side effects. There's no reliable way to predict which pattern you'll experience before insertion.

There is no estrogen, so the implant is suitable for women in whom estrogen is contraindicated (migraine with aura, certain clotting histories, breastfeeding).

The hormonal load question: what the evidence actually shows on mood

This is where the honest, imperfect answer lives. The evidence on hormonal contraception and mood is genuinely complicated — and most consultations either overstate the risk or dismiss it entirely.

A large Danish cohort study (Skovlund et al., 2016, NEJM) found an increased risk of first depression diagnosis and antidepressant prescriptions in women on hormonal contraception, with the highest risk in adolescents. The elevated risk was real but modest in absolute terms. Subsequent studies have found mixed results.

What seems clearer in the research: a subset of women — those with a personal or family history of mood disorders, or those who experienced premenstrual mood symptoms — are more likely to experience negative mood effects from exogenous progestogen. This isn't a contraindication; it's a flag to monitor and discuss.

The copper IUD has no hormonal component and shows no association with mood changes in the evidence base. For women who suspect hormonal contraception is affecting their mood, it's a meaningful alternative worth considering.

Fertility return after stopping each method

The pill: ovulation typically returns within 1–3 months. Some women return to their natural cycle within weeks. There is no evidence of long-term fertility impairment from the pill.

Hormonal IUDs: fertility returns almost immediately after removal. The IUD's effects are reversible within a menstrual cycle in most women.

Copper IUD: fertility returns immediately after removal.

Implant: fertility typically returns within 1–3 months of removal. Median time to ovulation after removal is approximately 3 weeks in studies.

The exception is the contraceptive injection (Depo-Provera, not discussed in detail here): fertility can take 10 months or longer to return — worth knowing if pregnancy is a goal within the next year or two.